Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
August 02, 2011
Illumina Books Orders for More than 135 MiSeqs, Starts Early-Access Shipments
The company's sequencing revenue increased 53 percent during the second quarter, largely due to sales of the HiSeq 2000. Overall revenues grew 36 percent, driven by "strong demand" for sequencing products and "an overall improvement" of the array business.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Amid Declining Revenues, Illumina Plans to Restructure, Focus on Clinical Market
October 25, 2011 / In Sequence - Illumina to Apply Rare-Cell Capture to Ovarian Cancer Program; Expects Clinical Apps for MiSeq
May 4, 2011 / Clinical Sequencing News - Illumina Sequencing Revenue Grows 70 Percent in Q4, Driven by HiSeq
February 15, 2011 / In Sequence - Illumina Obtains More Than 55 Gb from GA; Expects Large NIH Stimulus Awards for Sequencing
July 28, 2009 / In Sequence - MiSeq, Consumables, Services Drive Illumina's Q4 Revenues as it Begins Work on Nanopore Sequencing
January 29, 2013 / In Sequence